New GlaxoSmithKline CEO prepares for R&D choices, potential deals

LONDON (Reuters) - Emma Walmsley, GlaxoSmithKline's incoming CEO, will take over Britain's biggest drugmaker at a challenging time but the 47-year-old also inherits the flexibility to do deals and make key choices on new drugs.

from Reuters: Top News http://uk.reuters.com/article/uk-gsk-ceo-idUKKBN15L1E6?feedType=RSS&feedName=topNews